MLchartDataset catalogue

Tissue-agnostic therapy

Term · Oncology and biomedicine · MLC-T-ONC-008728

A type of therapy that uses drugs or other substances to treat cancer based on the cancer’s genetic and molecular features without regard to the cancer type or where the cancer started in the body. Tissue-agnostic therapy uses the same drug to treat all cancer types that have the genetic mutation (change) or biomarker that is targeted by the drug. It is a type of targeted therapy. Also called tumor-agnostic therapy.

Table 1. Record
IdentifierMLC-T-ONC-008728
FieldOncology and biomedicine
Synonymstumor-agnostic therapy
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-008728",
  "term": "Tissue-agnostic therapy",
  "field": "Oncology and biomedicine",
  "definition": "A type of therapy that uses drugs or other substances to treat cancer based on the cancer’s genetic and molecular features without regard to the cancer type or where the cancer started in the body. Tissue-agnostic therapy uses the same drug to treat all cancer types that have the genetic mutation (change) or biomarker that is targeted by the drug. It is a type of targeted therapy. Also called tumor-agnostic therapy.",
  "synonyms": [
    "tumor-agnostic therapy"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/tissue-agnostic-therapy/"
}

Record 16,400 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.